Cited by 88Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory

Open access
Cubillo, A., Smith, A. B., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., Rubia, K.·2014·Psychological Medicine

Abstract

Background The catecholamine reuptake inhibitors methylphenidate (MPH) and atomoxetine (ATX) are the most common treatments for attention deficit hyperactivity disorder (ADHD). This study compares the neurofunctional modulation and normalization effects of acute doses of MPH and ATX within medication-naive ADHD boys during working memory (WM). Method A total of 20 medication-naive ADHD boys underwent functional magnetic resonance imaging during a parametric WM n-back task three times, under a single clinical dose of either MPH, ATX or placebo in a randomized, double-blind, placebo-controlled, cross-over design. To test for normalization effects, brain activations in ADHD under each drug condition were compared with that of 20 age-matched healthy control boys. Results Relative to healthy boys, ADHD boys under placebo showed impaired performance only under high WM load together with significant underactivation in the bilateral dorsolateral prefrontal cortex (DLPFC). Both drugs normalized the performance deficits relative to controls. ATX significantly enhanced right DLPFC activation relative to MPH within patients, and significantly normalized its underactivation relative to controls. MPH, by contrast, both relative to placebo and ATX, as well as relative to controls, upregulated the left inferior frontal cortex (IFC), but only during 2-back. Both drugs enhanced fronto-temporo-striatal activation in ADHD relative to control boys and deactivated the default-mode network, which w…

Integrity signals

Registry

Crossref · 10.1017/s0033291713000676

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Testing single dose effects is valuable because they could be less confounded by longer-term purely developmental effects, side effects and clinical improvements that could indirectly affect cognition.

    “While testing longer-term effects on cognition is clinically relevant, testing single dose effects is also valuable because they could be less confounded by longer-term purely developmental effects, side effects and clinical improvements that could indirectly affect cognition (45).”
  • In the authors' four fMRI studies comparing single dosages of methylphenidate and atomoxetine versus placebo on brain activation in children and adolescents with ADHD, reduced activation in frontal, parietal, temporal, and insular-striatal regions during cognitive tasks can be increased (and even normalized) by both stimulant and non-stimulant medications.

    “Thus, in our four fMRI studies comparing the effects of single dosages of methylphenidate and atomoxetine versus placebo on brain activation in children and adolescents with ADHD (45, 85–87), we found that reduced activation in frontal, parietal, temporal, and insular-striatal regions during cognitive tasks can be increased (and even normalized) by both stimulant and non-stimulant medications.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cubillo, A., Smith, A. B., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., & Rubia, K.
Affiliations
King's College London (GB)
Corresponding author
Rubia, K.
Venue
Psychological Medicine
Published
2013-04-19
Volume
44
Issue
3
Pages
633-646
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W1976271649
Cited by
88
References
22
Citations by year
2026: 1 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 10 · 2016: 13 · 2015: 11 · 2014: 12 · 2013: 4
FWCI
9.45
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
attention deficit hyperactivity disorder, atomoxetine, methylphenidate, working memory, dorsolateral prefrontal cortex, inferior frontal cortex, default mode network
MeSH terms
Atomoxetine Hydrochloride, Adolescent, Analysis of Variance, Attention Deficit Disorder with Hyperactivity, Basal Ganglia, Brain Mapping, Child, Double-Blind Method, Frontal Lobe, Humans, Functional Laterality, Magnetic Resonance Imaging, Male, Memory, Short-Term, Methylphenidate, Neuropsychological Tests, Placebos, Propylamines, Neurotransmitter Uptake Inhibitors, Prefrontal Cortex, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review